Interestingly, we observed that increased SETD2 expression was accompanied by enhanced GATA3 expression in Treg cells in cancerous tissues from colorectal cancer (CRC) patients compared with noncancerous colorectal tissues (Fig. 6k–n). The gene discussed is GATA3; the disease is colorectal carcinoma.